Show simple item record

dc.contributor.authorDoebele, Ren
dc.contributor.authorAhn, Men
dc.contributor.authorSiena, Sen
dc.contributor.authorDrilon, Aen
dc.contributor.authorKrebs, Matthew Gen
dc.contributor.authorLin, Cen
dc.contributor.authorDe, Braud, Fen
dc.contributor.authorJohn, Ten
dc.contributor.authorTan, Den
dc.contributor.authorSeto, Ten
dc.contributor.authorDziadziuszko, Ren
dc.contributor.authorArkenau, Hen
dc.contributor.authorBarlesi, Fen
dc.contributor.authorRolfo, Cen
dc.contributor.authorWolf, Jen
dc.contributor.authorChow-Maneval, Een
dc.contributor.authorMultani, Pen
dc.contributor.authorCui, Nen
dc.contributor.authorRiehl, Ten
dc.contributor.authorCho, BCen
dc.date.accessioned2019-02-08T15:20:03Z
dc.date.available2019-02-08T15:20:03Z
dc.date.issued2018en
dc.identifier.citationDoebele R, Ahn M, Siena S, Drilon A, Krebs M, Lin C, et al. OA02.01Efficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC). J Thorac Oncol. 2018 Oct;13(10):S321-S322.en
dc.identifier.doi10.1016/j.jtho.2018.08.239en
dc.identifier.urihttp://hdl.handle.net/10541/621485
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jtho.2018.08.239en
dc.titleEfficacy and safety of entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Colorado, Aurora, CO/USen
dc.identifier.journalJournal of Thoracic Oncologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record